Imperagen
Imperagen

Imperagen

Measured by AhrefsDR4Ahrefs DR: 4/100. Bottom 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed65Site Speed: 65/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust63Data Trust: 63/100. Above median. Measured by StartupHub.ai. Median 61.

Biotech company developing novel drug delivery technologies.

2017ActiveCambridge, United Kingdom

About

Imperagen is a biotechnology company focused on developing innovative drug delivery systems. Their technology aims to improve the efficacy and patient experience of various therapeutic treatments.

Key facts

Website
imperagen.com
Headquarters
Cambridge, England, United Kingdom
Founded
2017
Total funding
$7M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Imperagen
DateRoundAmountLead investors
20 May 2026Seed$7MPXN Ventures

Tech stack

Detected on imperagen.com, last scanned 6 Nov 2026.

Analytics
Google Tag Manager
CMS / Builders
Lovable
CDN
Cloudflare
Email provider
Microsoft 365

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Imperagen trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Imperagen is 63 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Imperagen raised?

Imperagen has raised a total of $7M in funding. The most recent round on record is Seed.

SEC filings, insider activity, nonprofit links and pay benchmarks for Imperagen:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules